Thioguanine-Related Chronic Hepatotoxicity in a Child with Acute Myeloid Leukemia: A Case Report and Review

Basit Öğe Kaydı
dc.contributor.authorKarapinar, Tuba Hilkay
dc.contributor.authorOymak, Yesim
dc.contributor.authorEcevit, Cigdem
dc.contributor.authorYilmaz, Funda
dc.contributor.authorKarakoyun, Miray
dc.contributor.authorAy, Yilmaz
dc.contributor.authorVergin, Canan
dc.date.accessioned2019-10-27T20:25:11Z
dc.date.available2019-10-27T20:25:11Z
dc.date.issued2015
dc.departmentEge Üniversitesien_US
dc.description.abstractThe association between 6-Thioguanine (6-TG) treatment and drug-induced liver injury has been reported since 1976. Recent reports have suggested that treatment of patients with 6-TG can lead to chronic hepatotoxicity and portal hypertension. Most of the cases reported to have 6-TG related hepatotoxicity had acute lymphoblastic leukemia or inflammatory bowel disease. In this case report, we discussed the diagnosis and approach in an acute myeloid leukemia patient who developed 6-TG related chronic hepatotoxicity.en_US
dc.identifier.doi10.4274/jpr.69885
dc.identifier.endpage104en_US
dc.identifier.issn2147-9445
dc.identifier.issn2147-9445en_US
dc.identifier.issue2en_US
dc.identifier.startpage102en_US
dc.identifier.urihttps://doi.org/10.4274/jpr.69885
dc.identifier.urihttps://hdl.handle.net/11454/42207
dc.identifier.volume2en_US
dc.identifier.wosWOS:000219056100012en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofJournal of Pediatric Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject6-Thioguanineen_US
dc.subjecthepatotoxicityen_US
dc.subjectleukemiaen_US
dc.titleThioguanine-Related Chronic Hepatotoxicity in a Child with Acute Myeloid Leukemia: A Case Report and Reviewen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu